价格

B-type natriuretic peptide

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

SUSTAINED-RELEASE DRUG DELIVERY SYSTEMS COMPRISING AN INTRAOCULAR PRESSURE LOWERING AGENT, A CNP COMPOUND, AN NPR-B COMPOUND, A TIE-2 AGONIST, OR NEUROTROPHIC AGENT FOR USE FOR TREATING GLAUCOMA OR OCULAR HYPERTENSION
EP 3810082 A1申请人: CELLA THERAPEUTICS LLC优先权: 2018
CN
EP
US
WO
13 件公开
AGENT FOR THE TREATMENT OF ALOPECIA
EP 3269382 A1申请人: IGISU CO LTD优先权: 2011
CN
EP
US
8 件公开
MODIFIED B-TYPE NATRIURETIC PEPTIDE
- EP 4337668 A1
  申请人: ANTLIA BIOSCIENCE INC优先权: 2021
  CN
  EP
  US
  WO
  5 件公开
- WO 2025106567 A1
  申请人: ANTLIA BIOSCIENCE INC优先权: 2023
  WO
COMPOSITION FOR EXTERNAL PREPARATION FOR SKIN
US 2012208756 A1申请人: ENDO KYOKO优先权: 2009
US
5 件公开
THERAPEUTIC AGENT FOR RHINITIS
US 2013045921 A1申请人: IGISU COMPANY LTD优先权: 2009
US
5 件公开
Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
US 7632647 B2申请人: BIOSITE INC优先权: 2001
US
4 件公开
HUMAN ANTI-INFLAMMATORY PEPTIDES FOR THE INHALATORY TREATMENT OF INFLAMMATORY PULMONARY ISSUES
US 2023103704 A1申请人: ADVITA LIFESCIENCE GMBH优先权: 2020
EP
US
WO
3 件公开
ANTIBODIES BINDING SPECIFICALLY TO NT-PROBNP AND USE THEREOF
EP 4169946 B1申请人: BIONOTE INC优先权: 2021
EP
US
3 件公开
COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASE AND MYOCARDIAL INFARCTION WITH DIPEPTIDYL PEPTIDASE INHIBITORS OR B TYPE NATRIURETIC PEPTIDE ANALOGUES RESISTANT TO PROLYL-SPECIFIC DIPEPTIDYL DEGRADATION
US 2008045444 A1申请人: BIOSITE INC优先权: 2006
US
3 件公开
BONE REPAIR PROMOTER
US 2015125457 A1申请人: DAIICHI SANKYO CO LTD优先权: 2012
CN
US
2 件公开

药物

B-type natriuretic peptide

专利

MODIFIED B-TYPE NATRIURETIC PEPTIDE